• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Improving Cost-Effectiveness Analysis of Childhood Vaccines in Low- And Middle-Income Countries: Incorporating Equity and Budgetary Considerations

Funding period: 2014 - 2020

Completed

Related publications (3)

Scholarly works icon

Accounting for equity considerations in cost-effectiveness analysis: A systematic review of rotavirus vaccine in low and middle-income countries

MA Boujaoude, AJ Mirelman, K Dalziel, N Carvalho

2018-05-18

Background: Cost-effectiveness analysis (CEA) is frequently used as an input for guiding priority setting in health. However, CEA ..

Scholarly works icon

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework

N Carvalho, M Jit, S Cox, J Yoong, RCW Hutubessy

2018-01-01

Background: In low- and middle-income countries, budget impact is an important criterion for funding new interventions, particular..

Scholarly works icon

HOW ARE BUDGET IMPACT CONSIDERATIONS CAPTURED WITHIN ECONOMIC EVALUATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE FOCUSED ON ROTAVIRUS VACCINE

N Carvalho

2016-11-01

University of Melbourne Researchers

Natalie Carvalho's Profile Picture
Natalie Carvalho

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224